Recently, foreign pharmaceutical makers such as AbbVie, AstraZeneca, Novartis, Sanofi, and Roche slashed the prices of a large number of drugs sold in China, the world’s second largest drug market. They cut prices far below their prices in the United States (US) and elsewhere so Beijing would put these drugs...
Tag: Novartis
December 3, 2019
January 9, 2018
Chinese drug approval authorities likely to approve several blockbuster foreign drugs in 2018. Hyundai Motor Group faces declining sales growth in 2018 in large part due to political and economic challenges in China. China State-Owned Assets Supervision and Advisory Commission (SASAC) to issue new guidelines to improve behavior of state-owned…
February 9, 2015
China Banking Regulatory Commission (CBRC) encourages Chinese banks to use more domestic technology. China’s moves to fight tax avoidance by MNCs raise fears among foreign firms in China. American Chamber of Commerce in Beijing raises concern about Chinese agricultural policies. Chinese railway firm pursues railway project cancellation compensation from Mexico…
